|March 4, 2013|
|11:49 EDT||CLF, MNST||Stocks with call strike movement; MNST CLF|
Monster Beverage (MNST) June 55 call option implied volatility increased 3% to 43, Cliffs Natural (CLF) July 27 call option implied volatility increased 2% to 43 according to iVolatility.
News For MNST;CLF From The Last 14 Days
|February 5, 2016|
|06:42 EDT||CLF||Cliffs Natural solvency concerns mounting, says Deutsche Bank|
Deutsche Bank analyst Jorge Beristain says that while successful execution of the recently announced debt exchange offer could bring a short-term catalyst for shares of Cliffs Natural, it may not alter medium-term solvency concerns. Post the company's Q4 results, the analyst cut his price target for the shares to $1.00 from $1.50 on lower iron ore realizations. He believes solvency concerns are mounting and reiterates a Sell rating on Cliffs.
|February 1, 2016|
|16:24 EDT||CLF||Mesabi Trust receives royalty report of iron ore product shipments from Cliffs|
On January 29, the Trustees of Mesabi Trust (MSB) received the quarterly royalty report of iron ore product shipments from Silver Bay, Minnesota during the quarter ended December 31, 2015 from Cliffs Natural Resources (CLF), the parent company of Northshore Mining Company. As previously reported, on January 15, 2016, the Trustees declared a distribution of 5c per Unit of Beneficial Interest payable on February 20 to Mesabi Trust Unitholders of record at the close of business on January 30. As reported by Cliffs, based on shipments of iron ore products by Northshore during the three months ended December 31, 2015, Mesabi Trust was credited with a base royalty of $2.86M. Mesabi Trust also was credited with a bonus royalty in the amount of $271,153, based on the average sales price per ton of iron ore pellets and the volume of shipments by Northshore during the fourth calendar quarter of 2015. Royalties paid to Mesabi Trust, however, reflected a reduction of $797,170 as a result of negative pricing adjustments to base and bonus royalty calculations related to changes in price estimates made in the previous calendar quarters of 2015. Accordingly, the total royalty payments received on January 29, 2016 by Mesabi Trust from Northshore were $2.42M. The royalties paid to Mesabi Trust are based on the volume of shipments of iron ore pellets for the quarter and the year to date, the pricing of iron ore product sales, and the percentage of iron ore pellet shipments from Mesabi Trust lands rather than from non-Mesabi Trust lands. In the fourth calendar quarter of 2015, Northshore credited Mesabi Trust with 981,102 tons of iron ore, as compared to 1,244,364 tons during Q4 of 2014.
|11:18 EDT||MNST||Wells Fargo, Citron take sides in Monster Beverage debate|
Monster Beverage (MNST) is rising slightly in the down market after Wells Fargo upgraded the stock, saying that the shares have reached a compelling entry point while Monster's convenience store sales appear to have accelerated. UPGRADE: The recent weakness in Monster's stock has created a "compelling entry point," according to Wells Fargo analyst Bonnie Herzog, who upgraded the stock to Outperform from Market Perform. Moreover, Wells Fargo's survey of beverage retailers suggests that the company's sales at convenience stores rose 10% last quarter, up from 7% in Q3. Additionally, the survey found that the quality of Monster's distribution operation had greatly improved in recent months. As a result, Herzog wrote that the issues caused by the company's transition to using Coca-Cola's (KO) distribution system had been "largely resolved." Monster's earnings growth should accelerate over the next five years as it penetrates new overseas markets, including China, the analyst contended. There are "numerous scenarios" that would enable the beverage maker to beat earnings expectations going forward, Herzog believes. In addition to international expansion, the company could benefit from accelerated share buybacks, a reduced tax rate and "major innovations" in beverages outside of its core energy business, according to Herzog. She raised her price target on the shares to $159-$161 from $139-$141. SHORT REPORT: On January 29, short-selling research firm Citron wrote that Monster's "valuation..is completely removed from reality." Over the past five years, Monster's stock has surged 500%, even though its revenue has only increased 90%, the firm stated. Meanwhile, Coca-Cola's 2014 purchase of a stake in Monster will prevent the latter company from being acquired, as Coke is not interested in buying Monster, Citron contended. In China, Monster will have to cope with high start-up costs, tough competition and lower margins, Citron warned. Furthermore, the company's new products cannibalize its existing drinks, Citron believes. Also on January 29, the small Eastern European country of Latvia decided to ban sales of energy drinks to minors. PRICE ACTION: In late morning trading, Monster climbed 2% to $137.73. The stock dipped about 1.6% on Friday.
|10:00 EDT||MNST||On The Fly: Analyst Upgrade Summary|
Today's noteworthy upgrades include: Air Products (APD) upgraded to Buy from Neutral at UBS... American Airlines (AAL) upgraded to Outperform from Market Perform at Cowen... Axiall (AXLL) upgraded to Overweight from Neutral at JPMorgan... BASF (BASFY) upgraded to Buy from Hold at Societe Generale... CNH Industrial (CNHI) upgraded to Neutral from Underperform at BofA/Merrill... CU Bancorp (CUNB) upgraded to Outperform from Market Perform at Fig Partners... CaixaBank (CAIXY) upgraded to Hold from Sell at Societe Generale... Chipotle (CMG) upgraded to Neutral from Underperform at BofA/Merrill... Concho Resources (CXO) upgraded to Buy from Neutral at SunTrust... Continental Building (CBPX) upgraded to Buy from Hold at BB&T... Eastman Chemical (EMN) upgraded to Buy from Outperform at CLSA... Extreme Networks (EXTR) upgraded to Buy from Hold at Needham... Glacier Bancorp (GBCI) upgraded to Outperform from Market Perform at Fig Partners... IBERIABANK (IBKC) upgraded to Strong Buy from Outperform at Raymond James... Infineon (IFNNY) upgraded to Buy from Neutral at UBS... Jarden (JAH) upgraded to Outperform from Market Perform at Raymond James... Joy Global (JOY) upgraded to Overweight from Equal Weight at Barclays... KT Corporation (KT) upgraded to Overweight from Neutral at JPMorgan... Kennametal (KMT) upgraded to Neutral from Underperform at BofA/Merrill... L-3 Communications (LLL) upgraded to Buy on valuation at BofA/Merrill... Maximus (MMS) upgraded to Outperform from Market Perform at Raymond James... Micron (MU) upgraded to Neutral from Sell at Goldman... Monster Beverage (MNST) upgraded to Outperform from Market Perform at Wells Fargo... Newell Rubbermaid (NWL) upgraded to Outperform from Market Perform at Raymond James... Northrop Grumman (NOC) upgraded to Buy from Neutral at BofA/Merrill... PTC (PTC) upgraded to Buy from Neutral at Sterne Agee CRT... Peoples Bancorp (PEBO) upgraded to Outperform from Neutral at Boenning & Scattergood... Praxair (PX) upgraded to Buy from Neutral at UBS... Proofpoint (PFPT) upgraded to Outperform from In-Line at Imperial Capital... Seagate (STX) upgraded to Hold from Sell at Benchmark... Siemens (SIEGY) upgraded to Buy from Neutral at Nomura... Superior Drilling (SDPI) upgraded to Buy from Hold at Wunderlich... Vertex (VRTX) upgraded to Buy from Hold at Jefferies... Werner (WERN) upgraded to Strong Buy from Outperform at Raymond James... ZAIS Financial (ZFC) upgraded to Overweight from Equal Weight at Barclays.
|06:14 EDT||MNST||Monster Beverage upgraded to Outperform from Market Perform at Wells Fargo|
Wells Fargo analyst Bonnie Herzog upgraded Monster Beverage to Outperform saying the recent pullback in the shares provides a "compelling" entry point. The analyst points out her firm's recent beverage survey indicates Monster's U.S. distribution issues have largely been resolved and that the company's earnings are poised to reaccelerate in 2016 and beyond. Herzog raised her price target for Monster shares to $159-$161 from $139-$141. The energy drink maker closed Friday down $2.17 to $135.03 after Citron Research posted a cautious report on the company.
|January 29, 2016|
|12:50 EDT||MNST||Options with increasing put volume|
Options with increasing put volume: MNST STLD LC LPX DRII MEOH STMP VMW XRX XLP
|12:45 EDT||MNST||Monster Beverage puts active on Citron sees shares hitting $80 in near term|
Subscribe for More Information
|12:24 EDT||MNST||Citron sees Monster Beverage shares hitting $80 in near term|
Shares of Monster Beverage (MNST) are likely to hit $80 in the near term, Citron Research writes in a new research report on the energy drink maker. The short-selling research firm says valuing Monster versus Dr Pepper Snapple (DPS) results in 48% downside for the stock. "For the sake of the benefit of the doubt we used the post GMCR takeout value as a benchmark to get to $80 a share for Monster," Citron states. Monster shares are down $7.15, or 5%, to $130.05 in midday trading. Reference Link
|12:18 EDT||MNST||Citron puts $80 price target on Monster Beverage |
Subscribe for More Information
|11:14 EDT||MNST||Latvia to ban energy drink sales to minors, Nutra Ingredients reports|
Subscribe for More Information
|11:12 EDT||MNST||Monster Beverage weakness an overrreaction, says Stifel|
Stifel said Monster is underperforming on concerns that a ban on energy drink sales to those under 18 years of age in Latvia could spread to other countries. Stifel said the concerns are a considerable overreaction, creating a buying opportunity. The firm's analyst said Latvia is barely a rounding error of the global energy drink market, and likely less than 0.1% of Monster's sales.
|10:16 EDT||MNST||Options with increasing implied volatility: WMB W CERS RAD CRM GILD MNST|
Subscribe for More Information
|January 27, 2016|
|09:12 EDT||CLF||On The Fly: Pre-market Movers |
UP AFTER EARNINGS: Biogen (BIIB), up 5.6%... Hawaiian Holdings (HA), up 6.7%... Capital One (COF), up 1.5%. ALSO HIGHER: Capnia (CAPN), up 34.1% after entering into an exclusive distribution agreement with Bemes... Fate Therapeutics (FATE), up 18.6% after announcing that the FDA has cleared the company's investigational new drug application for ProTmune... Raptor Pharmaceutical (RPTP), up 12.1% after being upgraded to Buy from Neutral at Citi... Aquinox (AQXP), up 5.6% after Baker Bros. buys 140,786 shares in the company... Sunedison (SUNE), up 7.4% after SunEdison and Greenlight Capital announced that they have mutually agreed to corporate governance initiatives... Citizens Financial Group (CFG), up 3% after it will be added to the S&P 500... Terex (TEX), up 5.2% after being upgraded to Neutral from Underweight at JPMorgan. DOWN AFTER EARNINGS: Tupperware Brands (TUP), down 11.4%... VMware (VMW), down 6.5%... Textron (TXT), down 9.9%... Cliffs Natural (CLF), down 5.8%... Boeing (BA), down 6.2%... Fiat Chrysler (FCAU), down 3%... Apple (AAPL), down 3.4%. ALSO LOWER: Priceline (PCLN), down 2.9% after being downgraded to Neutral from Buy at Goldman... Bed Bath & Beyond (BBBY), down 4.2% after being downgraded at Citi and KeyBanc... Tripadvisor (TRIP), down 5.5% after being downgraded to Sell from Neutral at Goldman.
|08:07 EDT||CLF||Cliffs Natural sees FY16 CapEx $50M vs. $83M in FY15|
For 2016, Cliffs expects full-year sales volume of approximately 17.5 million tons from its U.S. Iron Ore business. In order to reduce pellet inventory levels and generate cash flow from working capital, the Company currently plans to produce approximately 16 million tons of iron ore pellets. Cliffs' full-year 2016 U.S. Iron Ore cash production cost per ton expectation is $50 - $55. The Company's cash cost of goods sold per ton expectation is $55 - $60, representing a reduction of $5 from the previously disclosed 2016 cash costs of goods sold per ton expectation of $60 - $65. Cliffs anticipates depreciation, depletion and amortization to be approximately $7 per ton for full-year 2016. The Company remains in active negotiations with the United Steelworkers and is committed to reaching a fair and equitable agreement. The current contract has been extended by mutual agreement of both parties. The contract extension covers approximately 2,200 USW-represented workers at Cliffs' Empire and Tilden mines in Michigan, and its United Taconite and Hibbing Taconite mines in Minnesota. Cliffs' full-year 2016 Asia Pacific Iron Ore expected sales and production volume is approximately 11.5 million tons. The product mix is expected to contain 50 percent lump and 50 percent fines. The Company expects full-year 2016 interest expense to be approximately $240 million, of which approximately $205 million is cash interest. Cliffs expects full-year 2016 capital expenditures to be $50 million, a significant reduction compared to 2015 expenditures of $83 million. The reduction is driven by the divestiture of the remaining coal assets as well as spending discipline exhibited in the U.S. Iron Ore business.
|08:06 EDT||CLF||Cliffs Natural reports Q4 US Iron Ore total sales volume 4.5M|
U.S. Iron Ore pellet sales volume in the fourth quarter of 2015 was 4.5 million tons, a 42 percent decrease when compared with 7.8 million tons sold in the fourth quarter of 2014. The decrease was driven principally by the termination of a customer contract, lower demand from U.S. mills and higher sales in the comparable quarter in the prior year from the delayed start-up of the 2014 shipping season. Cash production cost per ton in U.S. Iron Ore was $45.36, down 23 percent from $58.96 in the prior year's fourth quarter. The decrease was driven by lower employment costs, reduced maintenance and repair costs, and year-over-year lower energy rates. Reports Q4 US Iron Ore total production volume 4.5M. Fourth-quarter 2015 Asia Pacific Iron Ore sales volume of 2.9 million was flat compared to the fourth quarter of 2014.
|08:04 EDT||CLF||Cliffs Natural reports Q4 cont ops EPS (14c), consensus (26c)|
Subscribe for More Information
|January 26, 2016|
|14:32 EDT||CLF||Notable companies reporting before tomorrow's open|
Notable companies reporting before tomorrow's open, with earnings consensus, include Novartis (NVS), consensus $1.18... Boeing (BA), consensus $1.26... United Technologies (UTX), consensus $1.52... Biogen (BIIB), consensus $4.08... EMC (EMC), consensus 65c... General Dynamics (GD), consensus $2.38... Anthem (ANTM), consensus $1.22... Illinois Tool Works (ITW), consensus $1.21... State Street (STT), consensus $1.18... Norfolk Southern (NSC), consensus $1.24... Progressive (PGR), consensus 47c... St. Jude Medical (STJ), consensus $1.01... Rockwell Automation (ROK), consensus $1.33... Textron (TXT), consensus 83c... Hess (HES), consensus ($1.47)... Cliffs Natural (CLF), consensus (26c).